Page 85 - Read Online
P. 85

Jafri et al. Hepatoma Res 2018;4:54  I  http://dx.doi.org/10.20517/2394-5079.2018.36                                                    Page 7 of 8


               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2018.



               REFERENCES
               1.   Block TM, Alter HJ, London WT, Bray M. A historical perspective on the discovery and elucidation of the hepatitis B virus. Antiviral Res
                   2016;131:109-23.
               2.   Cope Z. Medical history of the Second World War Medicine and Pathology. Postgrad Med J 1952;28:644-5.
               3.   Ezzell C. Candidate cause identified of non-A, non-B hepatitis. Nature 1988;333:195.
               4.   Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B
                   viral hepititis genome. Science 1989;244:359-62.
               5.   Purcell R. The hepatitis C virus: overview. Hepatology 1997;26:11S-4S.
               6.   Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. Hepatitis C viral dynamics in vivo and the antiviral
                   efficacy of interferon-alpha therapy. Science 1998;282:103-7.
               7.   Rosenberg S. Recent advances in the molecular biology of hepatitis C virus. J Mol Biol 2001;313:451-64.
               8.   Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
               9.   Dubuisson J, Cosset FL. Virology and cell biology of the hepatitis C virus life cycle–an update. J Hepatol 2014;61:S3-13.
               10.  World Health Organization. Global hepatitis report, 2017. Available from: http://apps.who.int/iris/bitstream/handle/10665/255016/9789?seq
                   uence=1. [Last accessed on 17 Aug 2018]
               11.  Blach S, Zeuzem S, Manns M, Altraif I, Duberg AS, Muljono DH, Waked I, Alavian SM, Lee MH, Negro F, Abaalkhail F, Abdou A,
                   Abdulla M, Rached AA, Aho I, Akarca U, Al Ghazzawi I, Al Kaabi S, Al Lawati F, Al Namaani K, Al Serkal Y, Al-Busafi SA, Al-Dabal L,
                   Aleman S, Alghamdi AS, Aljumah AA, Al-Romaihi HE, Andersson MI, Arendt V, Arkkila P, Assiri AM, Baatarkhuu O, Bane A, Ben-Ari
                   Z, Bergin C, Bessone F, Bihl F, Bizri AR, Blachier M, Blasco AJ, Mello CE, Bruggmann P, Brunton CR, Calinas F, Chan HL, Chaudhry
                   A, Cheinquer H, Chen CJ, Chien RN, Choi MS, Christensen PB, Chuang WL, Chulanov V, Cisneros L, Clausen MR, Cramp ME, Craxi
                   A, Croes EA, Dalgard O, Daruich JR, de Ledinghen V, Dore GJ, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Farag E, Ferraz
                   ML, Ferreira PR, Flisiak R, Frankova S, Gamkrelidze I, Gane E, García-Samaniego J, Khan AG, Gountas I, Goldis A, Gottfredsson M,
                   Grebely J, Gschwantler M, Pessôa MG, Gunter J, Hajarizadeh B, Hajelssedig O, Hamid S, Hamoudi W, Hatzakis A, Himatt SM, Hofer H,
                   Hrstic I, Hui YT, Hunyady B, Idilman R, Jafri W, Jahis R, Janjua NZ, Jarčuška P, Jeruma A, Jonasson JG, Kamel Y, Kao JH, Kaymakoglu S,
                   Kershenobich D, Khamis J, Kim YS, Kondili L, Koutoubi Z, Krajden M, Krarup H, Lai MS, Laleman W, Lao WC, Lavanchy D, Lázaro P,
                   Leleu H, Lesi O, Lesmana LA, Li M, Liakina V, Lim YS, Luksic B, Mahomed A, Maimets M, Makara M, Malu AO, Marinho RT, Marotta
                   P, Mauss S, Memon MS, Correa MC, Mendez-Sanchez N, Merat S, Metwally AM, Mohamed R, Moreno C, Mourad FH, Müllhaupt B,
                   Murphy K, Nde H, Njouom R, Nonkovic D, Norris S, Obekpa S, Oguche S, Olafsson S, Oltman M, Omede O, Omuemu C, Opare-Sem O,
                   Øvrehus AL, Owusu-Ofori S, Oyunsuren TS, Papatheodoridis G, Pasini K, Peltekian KM, Phillips RO, Pimenov N, Poustchi H, Prabdial-
                   Sing N, Qureshi H, Ramji A, Razavi-Shearer D, Razavi-Shearer K, Redae B, Reesink HW, Ridruejo E, Robbins S, Roberts LR, Roberts SK,
                   Rosenberg WM, Roudot-Thoraval F, Ryder SD, Safadi R, Sagalova O, Salupere R, Sanai FM, Avila JF, Saraswat V, Sarmento-Castro R,
                   Sarrazin C, Schmelzer JD, Schréter I, Seguin-Devaux C, Shah SR, Sharara AI, Sharma M, Shevaldin A, Shiha GE, Sievert W, Sonderup M,
                   Souliotis K, Speiciene D, Sperl J, Stärkel P, Stauber RE, Stedman C, Struck D, Su TH, Sypsa V, Tan SS, Tanaka J, Thompson AJ, Tolmane
                   I, Tomasiewicz K, Valantinas J, Van Damme P, van der Meer AJ, van Thiel I, Van Vlierberghe H, Vince A, Vogel W, Wedemeyer H, Weis N,
                   Wong VW, Yaghi C, Yosry A, Yuen MF, Yunihastuti E, Yusuf A, Zuckerman E, Razavi H. Global prevalence and genotype distribution of
                   hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017;2:161-76.
               12.  World Health Organization. Eliminate hepatitis: WHO. Available from: http://www.who.int/mediacentre/news/releases/2017/eliminate-
                   hepatitis/en/. [Last accessed on 17 Aug 2018]
               13.  Conference Reports for NATAP. Five million Americans infected with the hepatitis C virus: a corrected estimate. Available from: http://
                   www.natap.org/2005/AASLD/aasld_49.htm. [Last accessed on 17 Aug 2018]
               14.  Lavanchy D. The global burden of hepatitis C. Liver Int 2009;29:74-81.
               15.  Umer M, Iqbal M. Hepatitis C virus prevalence and genotype distribution in Pakistan: comprehensive review of recent data. World J
                   Gastroenterol 2016;22:1684-700.
   80   81   82   83   84   85   86   87   88   89   90